NCT07182526 2025-09-19
Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome
Al-Mustansiriyah University
Phase 2 Recruiting
Clinical Trials
9 trialsNCT04105270 2025-09-11
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
Masonic Cancer Center, University of Minnesota
Phase 2 Recruiting
NCT03753685 2025-07-23
X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases
Fudan University
Phase 2 Active not recruiting
NCT06931119 2025-04-17
Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients
Rabin Medical Center
Phase 1 Not yet recruiting
NCT04942730 2024-05-07
FluBuBe
St. Petersburg State Pavlov Medical University
Phase 2 Completed
NCT03549650 2022-03-04
Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2 Terminated
NCT03469310 2021-05-11
Minimizing Narcotic Analgesics After Endocrine Surgery
DHR Health Institute for Research and Development
Phase 4 Completed
NCT03774680 2019-10-10
Targeted Polymeric Nanoparticles Loaded With Cetuximab and Decorated With Somatostatin Analogue to Colon Cancer
Al-Azhar University
Phase 1 Unknown
NCT03631459 2018-08-21
A Multicenter Real World Study of Kanglaite for Cancer Cachexia
Zhejiang Kanglaite Pharmaceutical Co.Ltd
Unknown